期刊
PROTEOMICS CLINICAL APPLICATIONS
卷 9, 期 1-2, 页码 235-252出版社
WILEY-V C H VERLAG GMBH
DOI: 10.1002/prca.201400137
关键词
Biomarker; Clinical proteomics; Diagnostics; LC-MS; MS; Proteomic classifiers
资金
- Danish Council for Strategic Research as part of the BIOMARKAPD Project in the frame of the EU JPND program
In the realm of clinical chemistry, the field of clinical proteomics, that is, the application of proteomic methods for understanding mechanisms and enabling diagnosis, prediction, measurement of activity, and treatment response in disease, is first and foremost a discovery and research tool that feeds assay development downstream. Putative new assay candidates generated by proteomics discovery projects compete with well-established assays with known indications, well-described performance, and of known value in specific clinical settings. Careful attention to the many options available in the design, execution, and interpretation of clinical proteomics studies is thus necessary for translation into clinical practice. We here review and discuss important options associated with clinical proteomics endeavors stretching from the planning phases to the final use in clinical chemistry.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据